Pulmonary embolism (PE) is a common, costly, and potentially lethal disease in the US. While patients with PE are almost universally treated as inpatients and their length of hospital stay (LOS) varies widely, there is evidence that outpatient care with low-molecular-weight heparins or early discharge of hospitalized patients are effective and safe options for up to 50% of patients with PE. However, physicians may be reluctant to treat patients with PE on an outpatient basis or with brief hospitalization when the perceived risk of mortality or experiencing a short-term adverse outcome is not well quantified. Therefore, the broad objective of this project is to develop a clinical prediction rule that accurately identifies low-risk patients with PE who are potential candidates for outpatient care or early discharge.
The specific aims are 1) to derive a clinical prediction rule that identifies patients with PE who have a very low 30-day mortality risk (<= 2%), and 2) to assess the performance of this rule in predicting other relevant outcomes (i.e., major bleeding, respiratory failure [RF], cardiogenic shock, cardiac arrest) or processes of care (i.e., thrombolysis, mechanical ventilation [MV], ICU admission, LOS, hospital readmission). This is a retrospective cohort study using 3 large and reliable databases, the PHC4 database, the MediQual Atlas database, and the National Death Index (NDI). These databases contain a rich set of clinical information and outcomes data. Our prediction rule for prognosis will be derived from 8,000 patients discharged with a diagnosis of PE from all acute care hospitals in Pennsylvania during the calendar years 2000-2001. Patients with PE will be identified using primary ICD-9-CM discharge codes for PE or secondary discharge codes for PE coupled with primary discharge codes that represent complications or treatments of PE. Baseline data that include 35 potential clinical predictors of short-term mortality in PE will be abstracted from the PHC4/Atlas databases. The primary outcome will be 30-day mortality ascertained from the NDI; secondary outcomes will be major bleeding, RF, cardiogenic shock, cardiac arrest, thrombolysis, MV, ICU admission, LOS, and readmission. Classification tree analysis will be used to construct a simple clinical prediction rule that identifies a 20% subgroup of all patients with a 30-day mortality rate of 2% or less. The predictive accuracy of this rule will be externally validated in an independent cohort of 4,000 patients with PE from calendar year 2002 using identical patient identification strategies as for the derivation cohort. The safety of this rule will be tested in the validation cohort by computing the proportion of very low-risk patients who die within 30-days or have another adverse outcome. This innovative application will derive a clinical prediction rule for prognosis that has the potential to improve the cost-effectiveness of the management for PE. The long-term goal of this project will be to validate and implement this rule in prospective studies to test its safety and effectiveness and to establish future admission/early hospital discharge recommendations for patients with PE.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21HL075521-01A1
Application #
6820223
Study Section
Health Services Organization and Delivery Study Section (HSOD)
Program Officer
Denholm, Elizabeth M
Project Start
2004-07-01
Project End
2006-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
1
Fiscal Year
2004
Total Cost
$148,500
Indirect Cost
Name
University of Pittsburgh
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Venetz, Carmen; Labarere, Jose; Jimenez, David et al. (2013) White blood cell count and mortality in patients with acute pulmonary embolism. Am J Hematol 88:677-81
Scherz, Nathalie; Labarere, Jose; Aujesky, Drahomir et al. (2012) Elevated admission glucose and mortality in patients with acute pulmonary embolism. Diabetes Care 35:25-31
Venetz, Carmen; Jimenez, David; Mean, Marie et al. (2011) A comparison of the original and simplified Pulmonary Embolism Severity Index. Thromb Haemost 106:423-8
Donze, Jacques; Labarere, Jose; Mean, Marie et al. (2011) Prognostic importance of anaemia in patients with acute pulmonary embolism. Thromb Haemost 106:289-95
Scherz, Nathalie; Labarere, Jose; Mean, Marie et al. (2010) Prognostic importance of hyponatremia in patients with acute pulmonary embolism. Am J Respir Crit Care Med 182:1178-83
Aujesky, Drahomir; Jiménez, David; Mor, Maria K et al. (2009) Weekend versus weekday admission and mortality after acute pulmonary embolism. Circulation 119:962-8
Aujesky, Drahomir; Mor, Maria K; Geng, Ming et al. (2009) Predictors of early hospital readmission after acute pulmonary embolism. Arch Intern Med 169:287-93
Aujesky, Drahomir; Mor, Maria K; Geng, Ming et al. (2008) Hospital volume and patient outcomes in pulmonary embolism. CMAJ 178:27-33
Ibrahim, Said A; Stone, Roslyn A; Obrosky, D Scott et al. (2008) Thrombolytic therapy and mortality in patients with acute pulmonary embolism. Arch Intern Med 168:2183-90;discussion 2191-2
Aujesky, Drahomir; Stone, Roslyn A; Kim, Sunghee et al. (2008) Length of hospital stay and postdischarge mortality in patients with pulmonary embolism: a statewide perspective. Arch Intern Med 168:706-12

Showing the most recent 10 out of 15 publications